About: Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 July 2015

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2015 (uk) im Oktober 2015 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 21 July 2015 (en) artículu científicu espublizáu en xunetu de 2015 (ast)
publication date	wds:Q60559888-78B8E074-60B0-4572-943D-B5A0D3407AE0
publication date	2015-07-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60559888-AFAF7F6D-E502-4E64-A942-36D7DBFEB2DB
language of work or name	English
cites work	wds:Q60559888-498E5D09-D2CA-4F92-A161-F43B7A84A6D9
cites work	A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
author name string	wds:Q60559888-2DB67739-F79A-4ECB-924E-D5BE9778AD42 wds:Q60559888-2F68D061-4A42-40C6-B8EF-2A6E28B7865D wds:Q60559888-B95E4C88-4626-480A-803F-3655FEB5A7DF
author name string	Christian M Moya Eva Vigo Verónica Outeiriño-Iglesias
rdfs:label	Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats (en) Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats (nl)
skos:prefLabel	Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats (en) Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats (nl)
name	Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats (en) Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats (nl)
author	wds:Q60559888-2BE7BFA5-0600-49AC-AF64-F4EBA0522339 wds:Q60559888-2F40C63B-245F-41BA-9AA5-78CC508F2307 wds:Q60559888-33CB0CC4-EEB2-48D2-A66C-BDBEFF880041 wds:Q60559888-711A93A2-354A-4348-9530-FBD853C2818D
author	Federico Mallo Lucas González-Matías Pilar Santisteban Marina Romaní-Pérez
title	wds:Q60559888-70FF1F06-D5CD-414B-B14D-29989F082F6D
title	Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats (en)
page(s)	wds:Q60559888-EC591E3F-CB44-4F38-ACD9-C9F2379AB7A0
page(s)	3559-3569
instance of	wds:Q60559888-0E806AD7-67CA-4F0F-99FA-0D8D3E33D8EC
instance of	scholarly article
main subject	wds:Q60559888-038B267D-E3CE-43D3-BF3A-D88ECC2A8BD7 wds:Q60559888-499CB383-FC8E-4D31-9871-6CD3F3546769
main subject	type-1 diabetes liraglutide
PubMed ID	wds:Q60559888-8ADBF851-8A1B-48D0-89DF-B8FBCAE02C94
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26196539
PubMed ID	26196539
published in	wds:Q60559888-F30958ED-4572-4E9A-A202-7E516A01E578
published in	Endocrinology
issue	wds:Q60559888-8BEDBA22-23B9-4371-802E-0AB1E0DBBB5D
volume	wds:Q60559888-930A50E5-10F9-4409-857D-A7664AFCEA82
issue	10
volume	156
DOI	wds:Q60559888-DB21FBF5-529A-4E09-BC01-BDAC47931759
DOI	http://dx.doi.org/10.1210/EN.2014-1685
DOI	10.1210/EN.2014-1685
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60559888
is cites work of	Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?' GLP-1 Analogue Liraglutide Enhances SP-A Expression in LPS-Induced Acute Lung Injury through the TTF-1 Signaling Pathway. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System COVID-19 and the endocrine system: exploring the unexplored Diabetes and Novel Coronavirus Infection: Implications for Treatment Heightened ACE Activity and Unfavorable Consequences in COVID-19 Diabetic Subjects Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease Diabetes and COVID-19: Global and Regional Perspectives Diabetes and COVID-19: evidence, current status and unanswered research questions Liraglutide Enhances the Activity of the ACE-2/Ang(1-7)/Mas Receptor Pathway in Lungs of Male Pups from Food-Restricted Mothers and Prevents the Reduction of SP-A Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review GLP-1 receptor agonist ameliorates experimental lung fibrosis Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients Reply: Possible impact of membrane ACE2 expression on COVID-19 infection
is cites work of	wds:Q57817179-383A1172-A0CE-4FD2-AF54-8C1544C08451 wds:Q95276824-05346858-20D2-416F-BC57-885131D8038F wds:Q96018023-B80F9240-A862-42EA-A9B2-CA759694E9AA wds:Q97536520-44B3BBD0-5C4D-48EA-AC55-AC322ADC60C5 wds:Q98158941-D59DB827-1356-4C34-B13F-DCB006DC784C wds:Q89052824-539ECC8B-427A-41E8-82BE-2064648BD2ED wds:Q99714269-5E381759-BE15-45F6-8849-BF8BEE3A6F04 wds:Q94497207-69EF21BA-E4E1-48A0-89E8-0D90B3350A2C wds:Q97084237-9DAB0FF8-79D1-46C8-8B00-FD99FBB13B21 wds:Q98947637-468D5275-8986-4A4A-821B-8542C493D9A8 wds:Q94671390-9E9D8C1B-495E-49D7-8B62-7AFA138BCA02 wds:Q60921592-F79E2251-ED79-426F-8A3F-11543E734964 wds:Q94553673-CEB294EB-7D17-4E2F-969B-C34C269B9C9F wds:Q98197535-7270EB3F-180F-4C15-8C57-A824DC3BBFAE wds:Q98199256-8AA5FB4C-0A65-4E8D-A296-8CB03E47FD41 wds:Q99408953-8AB3BCD0-4948-44E2-B3C9-900E28221F18 wds:Q55306779-F9034E34-ECD4-463A-988E-27B6FC55DCEC wds:Q91863990-08B32DE0-940D-4659-914B-E78CD8EFACAB wds:Q94594236-E50CA2CB-FCD3-4079-8F50-799C2F6DD455

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software